A targeting nanotherapy for abdominal aortic aneurysms

J Cheng, R Zhang, C Li, H Tao, Y Dou, Y Wang… - Journal of the American …, 2018 - jacc.org
Background Abdominal aortic aneurysm (AAA) is a leading cause of mortality and morbidity
in the elderly. Currently, there remain no effective drugs that can prevent the growth of …

[HTML][HTML] A Targeting Nanotherapy for Abdominal Aortic Aneurysms

J Cheng, R Zhang, C Li, H Tao, Y Dou, Y Wang… - Journal of the American …, 2018 - Elsevier
Background Abdominal aortic aneurysm (AAA) is a leading cause of mortality and morbidity
in the elderly. Currently, there remain no effective drugs that can prevent the growth of …

A Targeting Nanotherapy for Abdominal Aortic Aneurysms

J Cheng, R Zhang, C Li, H Tao… - Journal of the …, 2018 - pubmed.ncbi.nlm.nih.gov
Background Abdominal aortic aneurysm (AAA) is a leading cause of mortality and morbidity
in the elderly. Currently, there remain no effective drugs that can prevent the growth of …

[引用][C] A Targeting Nanotherapy for Abdominal Aortic Aneurysms

J Cheng, R Zhang, C Li, H Tao, Y Dou… - Journal of the American …, 2018 - cir.nii.ac.jp
A Targeting Nanotherapy for Abdominal Aortic Aneurysms | CiNii Research CiNii 国立情報学
研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学 …

A Targeting Nanotherapy for Abdominal Aortic Aneurysms.

J Cheng, R Zhang, C Li, H Tao, Y Dou… - Journal of the …, 2018 - europepmc.org
Background Abdominal aortic aneurysm (AAA) is a leading cause of mortality and morbidity
in the elderly. Currently, there remain no effective drugs that can prevent the growth of …